Use of 3, 4', 5-Trihydroxy-Stilbene-3-Beta-D-glucoside in Prepartion of Medicines For Treating and/or Preventing Ischemic Heart Disease
AssigneeShenzhen Neptunus Pharmaceutical Co., Ltd.
InventorsJinhua Zhao, Jiangping Xu, Hui Kang, Bing Wang, Jing Li, Hanlin Feng, Lin Yu
Life of this patent
Estimating the term…
Abstract
The present invention provides new use of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside. 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside has efficacies of anti-myocardial ischemia by intravenous injection and/or oral administration. It is advantageous that 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside as anti-myocardial ischemia drug is used to prepare the medicine for treating and/or preventing ischemic heart disease.
Claims11
A use of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside as shown in formula I in preparation of pharmaceuticals for treating and/or preventing ischemic heart disease, wherein said ischemic heart disease refers to asymptomatic myocardial ischemia, angina, myocardial infarction, ischemic cardiomyopathy, heart failure or sudden death
(canceled)
A use of pharmaceutical composition containing 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside in preparation of pharmaceutical to treat and/or prevent ischemic heart disease.
A method for treating ischemic heart disease comprising administering a subject an effective amount of 3,4′,5-trihydroxy-stilbene-3-β-D-glucoside as shown in formula I
Dependencies are inferred from the claim text.